OP0063 Three months results of a double-blind placebo controlled, phase-iii clinical trial of infliximab in active ankylosing spondylitis

SAT0307 Lesinurad Monotherapy in Gout Patients Intolerant to Xanthine Oxidase Inhibitors (Light): A Randomized, Double-Blind, Placebo-Controlled, 6-Month Phase III Clinical Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.2090 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 769.1-769 ◽

Cited By ~ 3

Author(s):

A.-K. Tausche ◽

R. Alten ◽

N. Dalbeth ◽

J. Kopicko ◽

N. Bhakta ◽

...

Keyword(s):

Clinical Trial ◽

Xanthine Oxidase ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Xanthine Oxidase Inhibitors

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2020.07.036 ◽

2020 ◽

Cited By ~ 1

Author(s):

Pascal Demoly ◽

Jonathan Corren ◽

Peter Creticos ◽

Frédéric De Blay ◽

Philippe Gevaert ◽

...

Keyword(s):

Clinical Trial ◽

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Sublingual Tablet ◽

Double Blind Placebo ◽

Dust Mite

DA-9601 for erosive gastritis: Results of a double-blind placebo-controlled phase III clinical trial

World Journal of Gastroenterology ◽

10.3748/wjg.v10.i16.2379 ◽

2004 ◽

Vol 10 (16) ◽

pp. 2379 ◽

Cited By ~ 24

Author(s):

Sang Yong Seol

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Erosive Gastritis ◽

Double Blind ◽

Double Blind Placebo ◽

Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis

Immunotherapy ◽

10.2217/imt-2016-0079 ◽

2017 ◽

Vol 9 (1) ◽

pp. 13-24 ◽

Cited By ~ 3

Author(s):

Uyanga Batbold ◽

Dmytro O Butov ◽

Galyna A Kutsyna ◽

Narantsetseg Damdinpurev ◽

Elena A Grinishina ◽

...

Keyword(s):

Clinical Trial ◽

Pulmonary Tuberculosis ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial

Trials ◽

10.1186/s13063-018-2602-y ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 13

Author(s):

Dean A. Fennell ◽

Emma Kirkpatrick ◽

Kelly Cozens ◽

Mavis Nye ◽

Jason Lester ◽

...

Keyword(s):

Clinical Trial ◽

Randomised Controlled Trial ◽

Study Protocol ◽

Controlled Trial ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Randomised Controlled

Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial

BioDrugs ◽

10.1007/s40259-020-00408-z ◽

2020 ◽

Vol 34 (3) ◽

pp. 381-393

Author(s):

Jinmei Su ◽

Mengtao Li ◽

Lan He ◽

Dongbao Zhao ◽

Weiguo Wan ◽

...

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Phase Iii ◽

Chinese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Targeting Danger Associated Molecular Pattern (DAMP) with CD24Fc to Reduce Acute Gvhd: Study Design on a Randomized Double Blind Placebo Controlled Phase III Clinical Trial (CATHY Study)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.12.741 ◽

2020 ◽

Vol 26 (3) ◽

pp. S180-S181

Author(s):

Pan Zheng ◽

Yang Liu ◽

Hegang Chen ◽

Martin Devenport ◽

Pavan Reddy ◽

...

Keyword(s):

Clinical Trial ◽

Study Design ◽

Acute Gvhd ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Molecular Pattern

Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial

Neurological Research ◽

10.1080/01616412.2020.1711648 ◽

2020 ◽

Vol 42 (4) ◽

pp. 286-290 ◽

Cited By ~ 1

Author(s):

Yi Dong ◽

Jiazhi Qu ◽

Zhijun Zhang ◽

Changjun Wang ◽

Qiang Dong

Keyword(s):

Clinical Trial ◽

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Phase Iii ◽

Stroke Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Pooled Data

SWOG S0820/PACES (Preventing Adenomas of the Colon with Eflornithine and Sulindac): A randomized, double-blind, placebo-controlled phase III clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps3627 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS3627-TPS3627

Author(s):

Jason A. Zell ◽

Joseph M. Unger ◽

Garnet L Anderson ◽

Elise D. Cook ◽

Robert S. Krouse ◽

...

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations

10.1183/13993003.congress-2021.rct207 ◽

2021 ◽

Author(s):

Laura Conejero Hall ◽

Luis Puente Maestu ◽

Myriam Calle Rubio ◽

Walter Girón ◽

Carlos José Alvarez Martínez ◽

...

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Copd Exacerbations